Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:LH NASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$439.70-0.4%$400.27$365.20▼$581.20$5.83B0.54265,709 shs162,103 shsDGXQuest Diagnostics$195.23+0.7%$194.85$164.65▼$213.50$21.61B0.6824,850 shs871,296 shsLHLabcorp$260.37+1.8%$263.79$239.75▼$293.72$21.31B0.91722,103 shs543,206 shsMEDPMedpace$432.80+0.6%$458.92$287.17▼$628.92$12.36B1.19414,089 shs233,162 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+1.21%+14.68%-7.50%-23.04%DGXQuest Diagnostics0.00%+4.67%-1.97%-3.48%+14.54%LHLabcorp0.00%+4.02%-1.65%-7.86%+7.92%MEDPMedpace0.00%+4.22%+10.01%-4.62%+46.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$439.70-0.4%$400.27$365.20▼$581.20$5.83B0.54265,709 shs162,103 shsDGXQuest Diagnostics$195.23+0.7%$194.85$164.65▼$213.50$21.61B0.6824,850 shs871,296 shsLHLabcorp$260.37+1.8%$263.79$239.75▼$293.72$21.31B0.91722,103 shs543,206 shsMEDPMedpace$432.80+0.6%$458.92$287.17▼$628.92$12.36B1.19414,089 shs233,162 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed0.00%+1.21%+14.68%-7.50%-23.04%DGXQuest Diagnostics0.00%+4.67%-1.97%-3.48%+14.54%LHLabcorp0.00%+4.02%-1.65%-7.86%+7.92%MEDPMedpace0.00%+4.22%+10.01%-4.62%+46.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 2.33Hold$501.5014.05% UpsideDGXQuest Diagnostics 2.50Moderate Buy$216.5810.94% UpsideLHLabcorp 2.73Moderate Buy$308.0018.30% UpsideMEDPMedpace 2.20Hold$467.087.92% UpsideCurrent Analyst Ratings BreakdownLatest CHE, MEDP, DGX, and LH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026DGXQuest Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)5/8/2026LHLabcorp Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)5/4/2026DGXQuest Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B) ➝ Buy (B+)5/1/2026LHLabcorp Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$334.004/29/2026CHEChemed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)4/27/2026CHEChemed Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$422.00 ➝ $436.004/27/2026CHEChemed Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/24/2026MEDPMedpace Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$522.00 ➝ $484.004/24/2026MEDPMedpace BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$500.00 ➝ $450.004/24/2026MEDPMedpace BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$460.00 ➝ $400.004/24/2026MEDPMedpace Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$565.00 ➝ $477.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.53B2.31$24.69 per share17.81$63.88 per share6.88DGXQuest Diagnostics$11.04B1.96$15.18 per share12.86$69.25 per share2.82LHLabcorp$13.95B1.53$24.87 per share10.47$106.45 per share2.45MEDPMedpace$2.53B4.89$17.01 per share25.44$20.95 per share20.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$265.24M$18.3523.9617.261.6510.23%27.18%17.38%8/4/2026 (Estimated)DGXQuest Diagnostics$992M$9.0521.5716.892.339.07%15.60%7.06%7/28/2026 (Estimated)LHLabcorp$876.50M$11.2923.0613.441.826.66%16.29%7.62%7/23/2026 (Estimated)MEDPMedpace$451.12M$15.9127.2023.342.2017.19%120.89%24.79%7/20/2026 (Estimated)Latest CHE, MEDP, DGX, and LH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q1 2026LHLabcorp$4.09$4.25+$0.16$3.35$3.51 billion$3.54 billion4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 million4/22/2026Q1 2026MEDPMedpace$3.74$4.28+$0.54$4.28$697.82 million$706.60 million4/21/2026Q1 2026DGXQuest Diagnostics$2.37$2.50+$0.13$2.24$2.83 billion$2.90 billion2/25/2026Q4 2025CHEChemed$7.02$6.42-$0.60$5.48$659.09 million$639.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.400.55%+10.76%13.08%16 YearsDGXQuest Diagnostics$3.441.76%+7.34%38.01%14 YearsLHLabcorp$2.881.11%N/A25.51%N/AMEDPMedpaceN/AN/AN/AN/AN/ALatest CHE, MEDP, DGX, and LH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/19/2026DGXQuest Diagnosticsquarterly$0.861.81%7/8/20267/8/20267/22/20265/18/2026CHEChemedquarterly$0.600.54%5/28/20265/28/20266/16/20264/9/2026LHLabcorpquarterly$0.721.05%5/29/20265/29/20266/11/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemed0.110.850.83DGXQuest Diagnostics0.671.181.08LHLabcorp0.681.731.54MEDPMedpaceN/A0.850.85Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%LHLabcorp95.94%MEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipCHEChemed3.33%DGXQuest Diagnostics0.88%LHLabcorp0.84%MEDPMedpace20.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,81113.27 million12.83 millionOptionableDGXQuest Diagnostics57,000110.70 million109.72 millionOptionableLHLabcorp71,00082.00 million81.31 millionOptionableMEDPMedpace6,20028.56 million22.71 millionOptionableCHE, MEDP, DGX, and LH HeadlinesRecent News About These CompaniesBronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor HarmMay 24 at 12:00 PM | newsfilecorp.comNMEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026May 24 at 11:50 AM | newsfilecorp.comNINVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDPMay 24 at 9:12 AM | businesswire.comAxxcess Wealth Management LLC Has $4.56 Million Holdings in Medpace Holdings, Inc. $MEDPMay 24 at 3:25 AM | marketbeat.comMEDP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026May 23 at 11:45 AM | newsfilecorp.comNBronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor HarmMay 22 at 12:00 PM | globenewswire.comMedpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMay 22 at 12:00 PM | prnewswire.comMEDP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026May 22 at 11:12 AM | newsfilecorp.comNCincinnati biopharma firm helmed by Medpace founder makes commercial debutMay 22 at 10:58 AM | bizjournals.comMEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmMay 22 at 10:16 AM | globenewswire.comMEDP Lawsuit Alert: Medpace Investors are Notified of the Ongoing Securities Class Action Over the Company's Potential Misstatements – Contact BFA Law if You Lost MoneyMay 22 at 6:47 AM | globenewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MEDPMay 21 at 3:33 PM | newsfilecorp.comNINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MEDPMay 21 at 3:10 PM | prnewswire.comINVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, RGRD Law Announces - MEDPMay 21 at 3:03 PM | globenewswire.comDeadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitMay 21 at 1:05 PM | globenewswire.comMEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Cancellation Rate Risks: SueWallStMay 21 at 9:00 AM | prnewswire.comSummit Creek Advisors LLC Lowers Stock Position in Medpace Holdings, Inc. $MEDPMay 21 at 7:42 AM | marketbeat.comMEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud LawsuitMay 20, 2026 | prnewswire.comROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MEDPMay 20, 2026 | globenewswire.comMedpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMay 20, 2026 | prnewswire.comMEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Growth Outlook: Levi & KorsinskyMay 20, 2026 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026The Crude Reality: Pullback Creates High-Conviction Opportunity in ChevronBy Jeffrey Neal Johnson | April 29, 20263 Overlooked Nuclear Fuel Supply Chain WinnersBy Nathan Reiff | April 26, 2026Did Qualcomm Just Put Apple in Check?By Jeffrey Neal Johnson | April 28, 2026Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?By Sam Quirke | May 4, 2026CHE, MEDP, DGX, and LH Company DescriptionsChemed NYSE:CHE$439.70 -1.85 (-0.42%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$439.27 -0.43 (-0.10%) As of 05/22/2026 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$195.23 +1.41 (+0.73%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$195.66 +0.42 (+0.22%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Labcorp NYSE:LH$260.36 +4.62 (+1.80%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$260.32 -0.05 (-0.02%) As of 05/22/2026 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Medpace NASDAQ:MEDP$432.80 +2.70 (+0.63%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$433.00 +0.20 (+0.05%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
